3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Completed
3
Unknown
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Melanoma
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioblastoma
2
Fibrosis
2
Colorectal Neoplasms
2
Cachexia
2
Vascular Malformations
1
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pneumonia
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Osteosarcoma
1
Obesity
1
Interventions
Cyclophosphamide
9
fludarabine
8
Interleukin-2
8
aldesleukin
7
Sunitinib
6
Everolimus
6
Bevacizumab
6
fludarabine phosphate
5
Sorafenib
5
Radiotherapy
4
Nivolumab
4
Gene Expression Profiling
4
Filgrastim
4
pembrolizumab
3
peginterferon alfa-2b
3
Stem Cell Transplantation
3
Radiotherapy, Intensity-Modulated
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Immunohistochemistry
3
Granulocyte Colony-Stimulating Factor
3
cabozantinib
2
atezolizumab
2
Thiotepa
2
Sodium Chloride
2
Reverse Transcriptase Polymerase Chain Reaction
2
Polymerase Chain Reaction
2
Mycophenolic Acid
2
Mesna
2
Immunoenzyme Techniques
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Kidney Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT03846128
2026-04-14
BIOSUNTOX
University Hospital, Rouen
Terminated
6 enrolled